Which has grown faster, BNTX or WST?

Over the past five years, WST grew revenue faster — BNTX at a 2.16% CAGR versus WST at 5.68%.

Does BNTX or WST pay a bigger dividend?

WST pays a dividend (0.25% yield), while BNTX is a former payer with no current dividend run rate.

Is BNTX or WST more profitable?

WST runs the higher net margin — BNTX at -44.73% versus WST at 16.98%.

How have BNTX and WST total returns compared?

Over the past 5 years, BNTX delivered -25.75% and WST delivered 16.17% annualized total return. Past performance doesn't predict future results.

BioNTech SE (BNTX) vs West Pharmaceutical Services, Inc. (WST)

A side-by-side comparison of BioNTech SE and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 11, 2026. Differences are shown without an overall score or investment verdict.

BNTX

BioNTech SE

$23.31B

$92.80HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

WST

West Pharmaceutical Services, Inc.

$24.73B

$351.37HealthcareDelayed quote: Aug 11, 2026, 4:02 PM EDT

Total return — BNTX vs WST

growth of $100 · dividends reinvested · last 7y

BNTX +560.4% (+31.0%/yr)WST +155.1% (+14.3%/yr)BNTX compounded faster over this window

BNTX WST

BNTX vs WST: by the numbers

•WST is the larger company ($24.73B vs $23.31B market cap).
•WST is profitable (16.98% net margin) while BNTX runs a net loss (-44.73%).
•WST grew revenue faster over the past five years (5.68% vs 2.16% CAGR).
•WST pays a dividend (0.25% yield), while BNTX is a former payer with no current dividend run rate.

Metrics side by side

Valuation

Metric	BNTX	WST
P/E ratio	N/A	45.03
Forward P/E	N/A	39.38
P/S ratio	7.15	7.55
P/B ratio	1.09	8.40
EV / EBITDA	N/A	28.82
FCF yield	6.37%	1.74%

Profitability

Metric	BNTX	WST
Gross margin	73.26%	36.77%
Operating margin	-22.63%	20.64%
Net margin	-44.73%	16.98%
ROE	-6.79%	18.89%
ROIC	-3.14%	13.62%

Dividends

Metric	BNTX	WST
Dividend yield	N/A	0.25%
Payout ratio	N/A	12.88%

Growth (annualized)

Metric	BNTX	WST
Revenue CAGR (5Y)	2.16%	5.68%
EPS CAGR (5Y)	N/A	7.85%
FCF CAGR (5Y)	N/A	8.74%
Total return CAGR (5Y)	-25.75%	-3.44%

Frequently asked

Which has grown faster, BNTX or WST?: Over the past five years, WST grew revenue faster — BNTX at a 2.16% CAGR versus WST at 5.68%.
Does BNTX or WST pay a bigger dividend?: WST pays a dividend (0.25% yield), while BNTX is a former payer with no current dividend run rate.
Is BNTX or WST more profitable?: WST runs the higher net margin — BNTX at -44.73% versus WST at 16.98%.
How have BNTX and WST total returns compared?: Over the past 5 years, BNTX delivered -25.75% and WST delivered 16.17% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BNTX analysis Full WST analysis Interactive comparison tool

Dig into the metrics

West Pharmaceutical Services P/E ratio West Pharmaceutical Services dividend yield BioNTech SE ROE West Pharmaceutical Services ROE BioNTech SE operating margin West Pharmaceutical Services operating margin BioNTech SE revenue growth West Pharmaceutical Services revenue growth BioNTech SE free cash flow West Pharmaceutical Services free cash flow

BioNTech SE & West Pharmaceutical Services appear in these rankings

25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 11, 2026.